Sichuan Kelun Pharmaceutical Co Ltd002422
▲ PositiveCapitalrelevance
Company repurchased shares, signaling confidence and supporting stock price.

Kelun Pharmaceutical announced that as of July 31, 2026, the company had repurchased 350,000 shares, representing 0.02% of total share capital, for a total amount of 10.37 million yuan, at a price range of 29.55 yuan to 29.702 yuan per share. In the first quarter of 2026, Kelun Pharmaceutical achieved revenue of 4.259 billion yuan and net profit attributable to the parent company of 454 million yuan.
Sichuan Kelun Pharmaceutical Co LtdCompany repurchased shares, signaling confidence and supporting stock price.